Chris Rallis

Track

Insider profile

Currently holds positions in Aeolus Pharmaceuticals Inc and Tenax Therapeutics Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Aeolus Pharmaceuticals Inc June 28, 2004 -
Independent Director Tenax Therapeutics Inc Dec. 15, 2011 -
Chris Rallis's trades of Fennec Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
436.33
Quantity 85,458
Value US$2,308,838
Transaction date
Proposed sale
Price
9.24
Quantity 1,775
Value US$16,401
Transaction date
Proposed sale
Price
6.82
Quantity 1,186
Value US$8,089
Transaction date
Proposed sale
Price
6.14
Quantity 6,409
Value US$39,344
Transaction date
Proposed sale
Price
7.85
Quantity 673
Value US$5,283
Transaction date
Proposed sale
Price
8.17
Quantity 6,796
Value US$55,550
Transaction date
Proposed sale
Price
8.34
Quantity 986
Value US$8,223
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-11
S Sale
77,389 -41.2%
71.33
US$3,334,334 		77,389 -41.2% 71.33 US$3,334,334
2026-05-11 2026-05-11
PrS Proposed sale
85,458
436.33
US$2,308,838 		85,458 436.33 US$2,308,838
2025-10-14 2025-10-10
S Sale
50,716 +2.8%
352.89
US$119,753 		50,716 +2.8% 352.89 US$119,753
2025-10-10 2025-10-10
PrS Proposed sale
1,775
9.24
US$16,401 		1,775 9.24 US$16,401
2025-07-07 2025-07-07
S Sale
1,119 -2.0%
8.71
US$9,746 		1,119 -2.0% 8.71 US$9,746
2025-04-11 2025-04-11
S Sale
1,409 -2.6%
4.95
US$6,975 		1,409 -2.6% 4.95 US$6,975
2025-02-14 2025-02-14
PrS Proposed sale
1,186
6.82
US$8,089 		1,186 6.82 US$8,089
2025-02-14 2025-02-14
S Sale
1,186 -2.2%
6.82
US$8,089 		1,186 -2.2% 6.82 US$8,089
2024-12-02 2024-12-02
PrS Proposed sale
6,409
6.14
US$39,344 		6,409 6.14 US$39,344
2024-12-02 2024-12-02
S Sale
6,409 -10.9%
6.14
US$39,351 		6,409 -10.9% 6.14 US$39,351
2024-10-10 2024-10-08
S Sale
1,406 -2.8%
4.53
US$6,369 		1,406 -2.8% 4.53 US$6,369
2024-07-08 2024-07-05
S Sale
1,173 -2.5%
6.03
US$7,073 		1,173 -2.5% 6.03 US$7,073
2024-04-15 2024-04-15
S Sale
800 -1.8%
10.45
US$8,360 		800 -1.8% 10.45 US$8,360
2024-03-27 2024-03-26
S Sale
2,114 -4.9%
10.97
US$23,191 		2,114 -4.9% 10.97 US$23,191
2023-12-28 2023-12-26
S Sale
1,390 -3.0%
10.90
US$15,151 		1,390 -3.0% 10.90 US$15,151
2023-11-20 2023-11-20
PlS Planned sale
269 -0.6%
8.25
US$2,219 		269 -0.6% 8.25 US$2,219
2023-08-18 2023-08-18
PrS Proposed sale
673
7.85
US$5,283 		673 7.85 US$5,283
2023-08-18 2023-08-18
S Sale
673 -1.5%
7.85
US$5,283 		673 -1.5% 7.85 US$5,283
2023-07-24 2023-07-24
PrS Proposed sale
6,796
8.17
US$55,550 		6,796 8.17 US$55,550
2023-07-24 2023-07-24
S Sale
6,796 -13.4%
8.17
US$55,523 		6,796 -13.4% 8.17 US$55,523
2023-07-06 2023-07-06
S Sale
2,207 -7.1%
8.47
US$18,693 		2,207 -7.1% 8.47 US$18,693
2023-05-19 2023-05-19
PlS Planned sale
925 -2.9%
7.36
US$6,808 		925 -2.9% 7.36 US$6,808
2023-05-19 2023-05-19
PlS Planned sale
833 -2.5%
7.36
US$6,131 		833 -2.5% 7.36 US$6,131
2023-04-17 2023-04-17
PrS Proposed sale
986
8.34
US$8,223 		986 8.34 US$8,223
2022-11-17 2022-11-17
PlS Planned sale
333 -1.1%
7.99
US$2,661 		333 -1.1% 7.99 US$2,661